SCHEMBL6945463

SCHEMBL6945463

Cc1nc(N2CCc3ccccc3CC2)c([N+](=O)[O-])c(=O)n1C(C)C

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DCTPP1 Q9H773 1/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
MAPT P10636 4/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
CYP1A2 P05177 1/20 0.39
GPR55 Q9Y2T6 1/20 0.39
POLB P06746 2/20 0.38
HTT P42858 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
LMNA P02545 2/20 0.37
EED O75530 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6952315 0.85 MAPT (0.42) MEN1KMT2AMAPTCYP3A4CYP2C9
SCHEMBL6952446 0.84 CYP2C9 (0.38) MEN1KMT2AMAPTCYP3A4CYP2C9
SCHEMBL6946348 0.82 MAPT (0.42) MEN1KMT2AMAPTCYP3A4CYP2C9
SCHEMBL6952584 0.81 CYP2C9 (0.40) MEN1KMT2AMAPTCYP3A4CYP2C9
SCHEMBL6953752 0.80 CYP2C9 (0.40) MEN1KMT2AMAPTCYP3A4CYP2C9
SCHEMBL6952859 0.80 CYP2C9 (0.40) MEN1KMT2AMAPTCYP3A4CYP2C9
SCHEMBL6952822 0.79 CYP2C9 (0.39) MEN1KMT2AMAPTCYP3A4CYP2C9
SCHEMBL6947618 0.79 CYP2C9 (0.37) MEN1KMT2AMAPTCYP3A4CYP2C9
SCHEMBL6950082 0.78 ALDH1A1 (0.39) MEN1KMT2AMAPTCYP3A4CYP2C9
SCHEMBL6949240 0.78 TSHR (0.46) MEN1KMT2AMAPTCYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed